| Core companion animal health | 26.39M |
| Other vaccines, pharmaceuticals and products | 7.04M |
| Total revenue, net | 33.43M |
| Cost of revenue | 19.71M |
| Gross profit | 13.72M |
| Selling and marketing | 5.49M |
| Research and development | 507K |
| General and administrative | 3.23M |
| Total operating expenses | 9.23M |
| Operating income (loss) | 4.49M |
| Interest and other expense, net | |
| Income (loss) before income taxes | 4.48M |
| Current tax expense | 123K |
| Deferred tax expense (benefit) | 1.01M |
| Total income tax expense (benefit) | 1.14M |
| Net income (loss) | 3.35M |
| Basic net income (loss) per share | 0.49 |
| Diluted net income (loss) per share | 0.45 |
| Weighted average outstanding shares used to compute basic net income (loss) per share | |
| Weighted average outstanding shares used to compute diluted net income (loss) per share | 7.45M |